(Q34086050)

30 July 2017

Levodopa prolongs life expectancy and is non-toxic to substantia nigra (English)

1 reference

30 July 2017

0 references

1 reference

1 reference

Rajput AH

1

1 reference

30 July 2017

1 October 2001

1 reference

30 July 2017

6

1 reference

Parkinsonism and Related Disorders

inferred from page(s)

published in

1 reference

30 July 2017

8

1 reference

30 July 2017

2

1 reference

30 July 2017

95-100

1 reference

Is idiopathic parkinsonism the consequence of an event or a process?

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900023-2

7 January 2021

Parkinsonism: onset, progression, and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900023-2

7 January 2021

Ageing and Parkinson's disease: substantia nigra regional selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900023-2

7 January 2021

Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900023-2

7 January 2021

Aromatic Amino Acids and Modification of Parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900023-2

7 January 2021

Reversible drug-induced parkinsonism. Clinicopathologic study of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900023-2

7 January 2021

Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900023-2

7 January 2021

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900023-2

7 January 2021

The oxidant stress hypothesis in Parkinson's disease: evidence supporting it

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900023-2

7 January 2021

L-dopa cytotoxicity to PC12 cells in culture is via its autoxidation.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900023-2

7 January 2021

Glia conditioned medium protects fetal rat midbrain neurones in culture from L-DOPA toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900023-2

7 January 2021

Nigrostriatal Dopaminergic Neurons Remain Undamaged in Rats Given High Doses of l-DOPA and Carbidopa Chronically

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900023-2

7 January 2021

Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900023-2

7 January 2021

Suppressive effect of L-dopa on dopamine cells remaining in the ventral tegmental area of rats previously exposed to the neurotoxin 6-hydroxydopamine.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900023-2

7 January 2021

Timely levodopa (LD) administration prolongs survival in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900023-2

7 January 2021

Dopa-responsive dystonia: pathological and biochemical observations in a case.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900023-2

7 January 2021

Chronic low-dose levodopa therapy in Parkinson's disease: an argument for delaying levodopa therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900023-2

7 January 2021

Is levodopa toxic to human substantia nigra?

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900023-2

7 January 2021

Dopa-responsive, nonprogressive juvenile parkinsonism: report of a case

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900023-2

7 January 2021

Does levodopa therapy delay death in Parkinson's disease? A review of the evidence.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900023-2

7 January 2021

Pulmonary embolism: an under-recognized yet frequent cause of death in parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900023-2

7 January 2021

Significance of parkinsonian manifestations in essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900023-2

7 January 2021

Clinicopathologic observations in essential tremor: report of six cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900023-2

7 January 2021

Long-term treatment response and fluorodopa positron emission tomographic scanning of parkinsonism in a family with dopa-responsive dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900023-2

7 January 2021

10.1016/S1353-8020(01)00023-2

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

11489674